Characteristics associated with response to subcutaneously administered anti-CGRP monoclonal antibody medications in a  real-world community cohort of persons living with migraine: A retrospective clinical and genetic study

CONCLUSIONS: In this real-world setting, anti-CGRP preventives reduced MDM persistently and had similar and large effect sizes on MDM reduction; however, clinical and genetic factors influenced response.PMID:38071464 | DOI:10.1111/head.14655

Source: Headache - December 10, 2023 Category: Neurology Authors: Bruce A Chase Irene Semenov Susan Rubin Steven Meyers Angela Mark Thomas Makhlouf Tanya T Chirayil Demetrius Maraganore Jun Wei Siqun L Zheng Jianfeng Xu Alexander Epshteyn Anna Pham Roberta Frigerio Katerina Markopoulou Source Type: research